EverQuote Form 4: Mendal Disposes 14k Shares via 10b5-1 Plan
Rhea-AI Filing Summary
EverQuote, Inc. (EVER) – Form 4 Insider Transaction
On 06/23/2025, CEO & President Jayme Mendal reported the sale of 14,360 Class A common shares executed on 06/20/2025. The disposition was carried out under a pre-arranged Rule 10b5-1 trading plan adopted 12/17/2024. The weighted-average sales price disclosed was $24.20, with individual trades ranging from $23.81 to $24.78.
Following the transaction, Mendal directly owns 558,789 Class A shares. No derivative securities were acquired or disposed of, and no other transactions were reported.
The filing contains no operational or earnings data. While executive sales can sometimes signal insider sentiment, sales executed pursuant to 10b5-1 plans are generally viewed as routine portfolio diversification rather than an immediate indicator of company outlook.
Positive
- None.
Negative
- CEO executed a sale of 14,360 shares, trimming direct ownership and potentially signaling modest insider bearishness.
Insights
TL;DR: CEO sold 14,360 shares under 10b5-1 plan; modest stake reduction leaves 558,789 shares—mildly negative governance signal, but routine.
The Form 4 shows a single sale at a weighted-average price of $24.20. The 10b5-1 plan disclosure reduces the likelihood of informational timing, yet investors often view any C-suite disposal as incrementally bearish. After the sale, the CEO still controls more than half a million shares, suggesting continued alignment. With no accompanying operational news, I view the impact as marginal.
TL;DR: Insider sale small relative to total holding; neutral impact on investment thesis.
The 14,360-share sale represents roughly 2.5% of Mendal’s reported holdings (558,789 post-sale). Trade size is too small to materially alter insider ownership structure or float. Execution via 10b5-1 plan indicates advance planning, mitigating concerns of opportunistic timing. I classify the filing as routine housekeeping with limited portfolio relevance.
FAQ
How many EverQuote (EVER) shares did CEO Jayme Mendal sell?
What price range were the EVER shares sold at?
How many shares does Jayme Mendal own after the transaction?
Was the transaction executed under a Rule 10b5-1 trading plan?
Did the Form 4 report any derivative transactions?